A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer

INTRODUCTION: To date, anti-vascular endothelial growth factor (VEGF) monoclonal antibody (mAb, bevacizumab), anti-VEGF receptor mAb (ramucirumab) and selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (sunitinib, sorafenib and apatinib) have been tested in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Zhi-Gang, Zhang, Zhong-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200090/
https://www.ncbi.nlm.nih.gov/pubmed/30410364
http://dx.doi.org/10.2147/OTT.S169484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200090/
https://www.ncbi.nlm.nih.gov/pubmed/30410364
http://dx.doi.org/10.2147/OTT.S169484

Ejemplares similares